Page last updated: 2024-09-04

moxifloxacin and Acute Liver Injury, Drug-Induced

moxifloxacin has been researched along with Acute Liver Injury, Drug-Induced in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (16.67)	29.6817
2010's	13 (72.22)	24.3611
2020's	2 (11.11)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
An, Z; Cong, L; Liu, L; Sun, Y; Yang, S; Zhao, R	1
Akhtar, SM; Kaur, H; Mittal, GK; Reddy, VASK	1
Deshpande, D; Gumbo, T; Magombedze, G; Srivastava, S	1
Alshammari, TM; Caffrey, AR; LaPlante, KL; Larrat, EP; Morrill, HJ; Quilliam, BJ	1
Bui, CL; Calingaert, B; Castellsague, J; Holick, CN; Kaye, JA; McQuay, LJ; Perez-Gutthann, S; Quinlan, S; Riera-Guardia, N; Rothman, KJ; Saltus, CW; Suzart, K; Wahl, PM; Wallander, MA	1
Chamorro Mohedano, J; Díaz Souza, P; Puerto Alonso, JL; Rojas Martín, E	1
Franco Hidalgo, S; García Lorenzo, R; Prieto de Paula, JM; Salado Valdivieso, I	1
Wintenberger, C	1
Colucci, G; Silzle, T; Solenthaler, M	1
Aryee, A; Bhagani, S; Breen, R; Cropley, I; Gadhok, R; Hopkins, S; Lipman, M; Murphy, M; Roberts, CH; Smith, C	1
Chalasani, NP; Hayashi, PH	1
Juurlink, DN; Mamdani, MM; Manno, M; Paterson, JM	1
Avila, S; González, A; Lancho, A; López-Rosés, L; Santos, E; Soto, S; Urraca, B	1

Reviews

1 review(s) available for moxifloxacin and Acute Liver Injury, Drug-Induced

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

17 other study(ies) available for moxifloxacin and Acute Liver Injury, Drug-Induced

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology, 2011, Volume: 7, Issue:12 Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests	2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Moxifloxacin Induced Liver Injury by Causing Disease markers, 2022, Volume: 2022 Topics: Animals; Butyric Acid; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Humans; Moxifloxacin; Rats; RNA, Ribosomal, 16S	2022
Moxifloxacin induced encephalopathy in disseminated tuberculosis: A case report. The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3 Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Deprescriptions; Discitis; Electroencephalography; Encephalitis; Humans; Male; Moxifloxacin; Neurotoxicity Syndromes; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tuberculosis, Spinal	2020
Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet! Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:suppl_3 Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Humans; Liver; Models, Biological; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Time Factors; Tuberculosis	2018
Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014, Jan-01, Volume: 71, Issue:1 Topics: Adult; Aged; Alcoholism; Anti-Bacterial Agents; Aza Compounds; Case-Control Studies; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Comorbidity; Data Interpretation, Statistical; Databases, Factual; Female; Fluoroquinolones; Hospitals, Veterans; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Patient Safety; Quinolines; Retrospective Studies; Risk Factors; Socioeconomic Factors; United States; United States Department of Veterans Affairs	2014
Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study. Pharmacotherapy, 2014, Volume: 34, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Fluoroquinolones; Humans; Incidence; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Risk	2014
[Fatal acute hepatitis and cholestasis associated with liver disease]. Medicina clinica, 2010, Mar-20, Volume: 134, Issue:8 Topics: Acute Disease; Anti-Infective Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Cholestasis; Fatal Outcome; Fluoroquinolones; Humans; Liver Diseases, Alcoholic; Male; Middle Aged; Moxifloxacin; Quinolines	2010
[Moxifloxacin and hepatic toxicity]. Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:10 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Fluoroquinolones; Humans; Male; Maxillary Sinusitis; Moxifloxacin; Quinolines	2009
Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections. Prescrire international, 2009, Volume: 18, Issue:103 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bronchitis; Chemical and Drug Induced Liver Injury; Europe; Fluoroquinolones; Humans; Long QT Syndrome; Moxifloxacin; Pneumococcal Infections; Quinolines; Respiratory Tract Infections; Safety-Based Drug Withdrawals; Sinusitis; Stevens-Johnson Syndrome	2009
[Highlights of the Congress of the National Infectious Disease Medicine Days 2010]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:1 Suppl 1 Topics: Anti-Bacterial Agents; Arthritis, Infectious; Aza Compounds; Bacterial Infections; beta-Lactamases; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Resistance, Microbial; Fluoroquinolones; France; Humans; Infectious Disease Medicine; Moxifloxacin; Multicenter Studies as Topic; Osteitis; Prosthesis-Related Infections; Quinolines; Societies, Medical; Treatment Outcome	2011
Pyrazinamide-induced sideroblastic anemia. American journal of hematology, 2012, Volume: 87, Issue:3 Topics: 5-Aminolevulinate Synthetase; alpha-Thalassemia; Anemia, Sideroblastic; Antitubercular Agents; Aza Compounds; Bone Marrow; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Hemolysis; Humans; Isoniazid; Middle Aged; Moxifloxacin; Peritonitis, Tuberculous; Pyrazinamide; Pyridoxine; Quinolines; Rifampin	2012
Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011, Volume: 15, Issue:9 Topics: Antitubercular Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Cohort Studies; Drug Therapy, Combination; Fluoroquinolones; Humans; Logistic Models; Moxifloxacin; Multivariate Analysis; Quinolines; Retrospective Studies; Tuberculosis	2011
Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2012, Oct-02, Volume: 184, Issue:14 Topics: Anti-Bacterial Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines	2012
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2012, Oct-02, Volume: 184, Issue:14 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Case-Control Studies; Chemical and Drug Induced Liver Injury; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines	2012
Moxifloxacin-induced acute liver injury. The American journal of gastroenterology, 2002, Volume: 97, Issue:7 Topics: Acute Disease; Aged; Anti-Infective Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines	2002